Records containing: Idiopathic Retroperitoneal Fibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-05-25Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis. A Prospective Multicentric Study
-
CLINICAL_TRIALS study record update · 2021-03-22A Prospective, Controlled, Interventional Study to Evaluate the Efficacy and Safety of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis
-
CLINICAL_TRIALS study record update · 2021-03-19A Prospective Study to Evaluate the Efficacy and Safety of Cyclophosphamide in the Treatment of Idiopathic Retroperitoneal Fibrosis
-
CLINICAL_TRIALS study record update · 2020-03-19National Registry of Idiopathic Retroperitoneal Fibrosis in China
-
CLINICAL_TRIALS study record update · 2020-03-18A Prospective Cohort Study of Idiopathic Retroperitoneal Fibrosis in China
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2010-11-15Medical Therapy in Idiopathic Retroperitoneal Fibrosis: a Multicenter, Randomized, Controlled Trial of Prednisone vs Low-dose Prednisone Plus Methotrexate